One study found that MxA, IFI6, OAS1, ISG15, and IFI44L expression was significantly higher in patients with non-treated early RA than in those with established RA, and a significant and sustained decrease in IGS expression was found after 6 months of treatment (14). This evidence concerns the gene IFI44L and rheumatoid arthritis.